Abstract: An electronic device in a wireless communication system and a wireless communication method, including plural cells including current cells and at least one neighbouring cell. The electronic device includes: a transceiver; a first trigger circuit configured to enable the transceiver to conduct a first measurement report, to assist in starting a relay process for enabling the electronic device to communicate with a current cell via a relay user equipment; a second trigger circuit configured to enable the transceiver to conduct a second measurement report, to assist in starting a handover process for enabling the electronic deice to be switched from the current cell to the neighbouring cell; and one or more processing circuits configured to control the first and second trigger circuits, to enable the transceiver to conduct the first measurement report before conducting the second measurement report.

Abstract: Compounds having a structure of Formula (IX): or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof, wherein R1, R2a, R2b, R3a, R3b, R4a, R4b, Q1-Q2, R6, R7, A, B, W, x, and y are as defined herein and are provided. Pharmaceutical compositions comprising such compounds and methods for treating various HAT-related conditions or diseases, including cancer, by administration of such compounds are also provided.

Abstract: The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit RNA-containing virus, particularly the hepatitis C virus (HCV). Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

Abstract: An electronic device for wireless communications and a wireless communications method. The electronic device includes one or more processors. The processor is configured to determine the current carrier aggression status of first user equipment in response to a proximity-based service direct communication requirement of the first user equipment. The processor is further configured to determine a radio resource configuration of the first user equipment based on the carrier aggression status of the first user equipment, the radio resource configuration being used for proximity-based service direct communication of the first user equipment.

Abstract: A method for image segmentation includes acquiring a three-dimensional (3D) image that includes a plurality of two-dimensional (2D) images arranged in a spatial order. The method also includes determining a preliminary seed point in a first 2D image of the plurality of 2D images. The method further includes determining, based on the preliminary seed point, a final seed point in a second 2D image of the plurality of 2D images, and determining, based on the final seed point, a volume of interest (VOI) in the 3D image.

Abstract: The present invention relates to compounds according to Formula 1 and pharmaceutically acceptable salts, synthesis, intermediates, formulations, and methods of disease treatment therewith, including cancer, lymphocyte homing, chronic inflammation, neuropathic pain, fibrotic diseases, thrombosis, and cholestatic pruritus, mediated at least in part by ATX.

Abstract: Compounds having a structure of Formula (IX): or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof, wherein R1, R2a, R2b, R3a, R3b, R4a, R4b, Q1----Q2, R6, R7, A, B, W, x, and y are as defined herein and are provided. Pharmaceutical compositions comprising such compounds and methods for treating various HAT-related conditions or diseases, including cancer, by administration of such compounds are also provided.

Abstract: An apparatus and method for wireless communications, a base station, and a user equipment side apparatus in a communication system.

Abstract: A method for extracting a blood vessel may include acquiring an image relating to a blood vessel, the image including multiple slices; determining a region of interest in the image; establishing a blood vessel model; and extracting the blood vessel from the region of interest based on the blood vessel model.

Abstract: Various embodiments are generally directed to techniques for incorporating full-resolution frames in a coding order and corresponding thumbnail images of a motion video into compressed video data. A device to compress video frames includes a processor component; and a compression component for execution by the processor component to intersperse at least one compressed thumbnail frame (T-frame) among multiple compressed full-resolution frames of a motion video arranged in a coding order in a compressed video data, the T-frame comprising multiple thumbnail images of the motion video in compressed form. Other embodiments are described and claimed.

Abstract: The present invention provides a method for preparing dendritic cell loaded with antigen, the method comprising the steps of adding serum-free cell culture medium containing granulocyte-macrophage colony-stimulating factor (GM-CSF) and inter-leukin (IL)-4 into mononuclear cells, culturing in an incubator at 37° C. under 5% carbon dioxide for 5 days, adding target antigen wrapped cationic liposome and culturing for 8-24 hours to obtain target antigen loaded dendritic cell.

Abstract: An electronic device on a user equipment side in a wireless communication system and a wireless communication method. The electronic device includes: a communication unit, configured to implement device-to-device (D2D) communication under a cellular communication protocol with multiple user equipments, to directly send data and/or control information to the multiple user equipments; and a configuration unit, configured to configure, for a first user equipment and a second user equipment in the multiple user equipments, resources and a modulation and coding scheme (MCS) for implementing D2D communication between the first user equipment and the second user equipment, wherein the second user equipment is a candidate that the first user equipment implements D2D communication with, and the communication unit send information indicating the resources and the MCS to the first user equipment and the second user equipment.

Abstract: The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit RNA-containing virus, particularly the hepatitis C virus (HCV). Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

Abstract: A method and system for image processing is provided. The technique includes acquiring data related to the processing, performing a pre-processing of the data, performing a segmentation of a subject, performing a post-processing of the result of the segmentation and managing storage of the data. The post-process includes a calibrating and a rendering of the data.

Abstract: The present invention relates to compounds according to Formula 1 and pharmaceutically acceptable salts, synthesis, intermediates, formulations, and methods of disease treatment therewith, including cancer, lymphocyte homing, chronic inflammation, neuropathic pain, fibrotic diseases, thrombosis, and cholestatic pruritus, mediated at least in part by ATX.

Abstract: The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit RNA-containing virus, particularly the hepatitis C virus (HCV). Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

Abstract: The present invention relates to compounds according to Formula I and pharmaceutically acceptable salts, synthesis, intermediates, formulations, and methods of disease treatment therewith, including cancer, lymphocyte homing, chronic inflammation, neuropathic pain, fibrotic diseases, thrombosis, and cholestatic pruritus, mediated at least in part by ATX.

Abstract: The disclosure discloses a method and device for performing peak clipping to multiple carrier waves, the method includes: according to carrier wave number of configured multiple carrier waves, signal bandwidth and occupied bandwidth of each carrier wave, obtaining total signal bandwidth and total occupied bandwidth of the corresponding carrier waves; according to the total signal bandwidth and the total occupied bandwidth of the multiple carrier waves, generating a digital filter with set order, and obtaining filter coefficient of the digital filter; taking the filter coefficient as a peak clipping coefficient and using the peak clipping coefficient to perform peak clipping to the peak-to-average ratio signals of the carrier waves. By the disclosure, the complexity of the generation of the peak clipping coefficient is simplified, the deterioration degree of EVM is reduced, and the distortion degree of signals is also reduced.

Abstract: The invention is a method and a system for updating pre-distortion coefficients, which is used to solve the problem of interference with neighbor cells due to the inferior pre-distortion coefficients. The method includes: presetting a primary table and a standby table, which store default and updated pre-distortion coefficients respectively; when a data source of a pre-distortion processor adopts the standby table, adopting the updated pre-distortion coefficients to perform parameter output processing to acquire pre-distortion parameters, and conveying the pre-distortion parameters and an input signal to the pre-distortion processor to process to acquire pre-distortion signals; conveying the pre-distortion signals through various signal processors to acquire a first signal, and determining the power data of the first signal; and based on the comparing result of the power data of the first signal and a setting range, there are different actions.

Abstract: Compounds having a structure of Formula (IX): or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof, wherein R1, R2a, R2b, R3a, R3b, R4a, R4b, Q1- - - -Q2, R6, R7, A, B, W, x, and y are as defined herein and are provided. Pharmaceutical compositions comprising such compounds and methods for treating various HAT-related conditions or diseases, including cancer, by administration of such compounds are also provided.